300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Cryptocurrency
Social Impact
Film
SaaS
Restaurants
Email
Photography
Payments
CleanTech
Marketplace
Energy
Organic Food
Fitness
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Blockchain
B2B
Social Network
Video Games
Medical Device
Big Data
Mobile
Wellness
Automotive
Sports
Legal
Education
eSports
Construction
Hospitality
Consumer
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Infrastructure
Medical
Cannabis
LGBT
Recruiting
Celebrity
Climate
Web3
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Manufacturing
Real Estate
Sporting Goods
Financial Services
Digital Media
Social Media
Franchise
FinTech
Mobile Advertising
Finance
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Isle of Man
Iran
Madagascar
Romania
Pakistan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Morocco
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Turkey
Malawi
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Rwanda
Philippines
El Salvador
Tanzania
Senegal
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Argentina
Spain
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Bangladesh
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
ZACROS Japan, VC Fund

ZACROS Japan

VC Fund

Tokyo, Japan

ZACROS Japan is a healthcare company that offers optoelectronics services.

Total investments:
3
Last investment:
Lead investor:
0%

Last updated:

Industries ZACROS Japan invests in

Health CareMedical DeviceBiotechnologyMachine LearningHealth Diagnostics

Stages ZACROS Japan invests in

Venture - Series Unknown

Countries ZACROS Japan invests in

Japan

Contacts

NameEmailPhoneSocials
Taku Shimoda Taku Shimoda

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Investment Focus

Industry

  • Health Care 3 (100%)
  • Medical Device 2 (67%)
  • Biotechnology 1 (33%)
  • Machine Learning 1 (33%)
  • Health Diagnostics 1 (33%)
See all 6 industries →

Team

NameTitleInvestmentsLinksEmail
Taku Shimoda
Taku Shimoda Executive Officer, Marketing & Business Planning Dept.; President & CEO
Executive Officer, Marketing & Business Planning Dept.; President & CEO Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Revorf Revorf
Revorf analyzes data and develops AI-related to infectious diseases and healthcare. $42.1M / Venture - Series Unknown / Aug 26, 2024
MiCAN Technologies MiCAN Technologies
MiCAN Technologies medical and nursing Care company we will provide the enabling tools to eliminate Malaria and other infectious diseases by the use of pluripotent stem cell. MiCAN Technologies through the provision of “blood cell-like cell products” produced using regenerative medicine technology,They will help you research malaria and otherinfectious and immune system diseases. $1.4M / Venture - Series Unknown / Aug 07, 2023
Cyfuse Biomedical Cyfuse Biomedical
Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally. The company offers 3D BioFabrication systems and related consumables; develops and licenses 3D tissue products for therapeutic and drug development use; and engages in contract manufacturing of 3D tissue products for research purposes.Itsproducts applications include blood vessel grafts for blood access of hemodialysis patients or coronary artery bypass grafts; cardiac grafts for drug toxicology screening or supplemental therapy of myocardial infarction; cartilage grafts for plastic surgery or reconstruction; and hepatocyte grafts for drug metabolism screening or in-vivo production of clotting factors in the treatment of hemophilia.Cyfuse Biomedical was founded in 2010 and is based in Tokyo, Japan. Venture - Series Unknown / Jan 29, 2021

Co-Investors

UntroD Capital UntroD Capital 2 deals together
Beyondge Beyondge 1 deal together
Bio Engineering Capital Bio Engineering Capital 1 deal together
Nippon Venture Capital Nippon Venture Capital 1 deal together
Shimadzu Shimadzu 1 deal together
Sumitomo Corporation Sumitomo Corporation 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Cryptocurrency
Social Impact
Film
SaaS
Restaurants
Email
Photography
Payments
CleanTech
Marketplace
Energy
Organic Food
Fitness
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Blockchain
B2B
Social Network
Video Games
Medical Device
Big Data
Mobile
Wellness
Automotive
Sports
Legal
Education
eSports
Construction
Hospitality
Consumer
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Infrastructure
Medical
Cannabis
LGBT
Recruiting
Celebrity
Climate
Web3
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Manufacturing
Real Estate
Sporting Goods
Financial Services
Digital Media
Social Media
Franchise
FinTech
Mobile Advertising
Finance
Non Profit
Android
Internet
Sustainability
Hardware
Biotech
Impact
Enterprise
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Isle of Man
Iran
Madagascar
Romania
Pakistan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Morocco
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Turkey
Malawi
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Sierra Leone
Rwanda
Philippines
El Salvador
Tanzania
Senegal
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Argentina
Spain
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Bangladesh
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does ZACROS Japan invest in?

ZACROS Japan invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact ZACROS Japan?

Public channels for ZACROS Japan include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at ZACROS Japan?

The team at ZACROS Japan includes Taku Shimoda (Executive Officer, Marketing & Business Planning Dept.; President & CEO). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
ZACROS Japan ZACROS Japan Find emails